StockData
OCSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as OCSAW

Oculis Holding AG

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 4, 2026
$7.32+0.03 (+0.41%)

Close on Oct 19, 2026

Oculis statistics

Financials through Dec 31, 2025, price-based ratios appear once a share price is available, median of Pharmaceutical Preparations companies for comparison

Income (trailing twelve months)

MeasureOculisIndustry median
Operating Income-CHF 81.67M-CHF 69.32M
Pretax Income-CHF 99.14M-CHF 70.45M
EBITDA-CHF 81.67M-CHF 69.32M
EPS (Diluted)-1.89 CHF-1.65 CHF

Returns

MeasureOculisIndustry median
Return on Capital Employed (ROCE)-41.0%-63.8%

Balance sheet

MeasureOculisIndustry median
Cash & Short-Term InvestmentsCHF 81.33MCHF 26.80M
Net Cash (Debt)CHF 81.33MCHF 26.80M
Net Cash Per Share1.35 CHF1.13 CHF
Working CapitalCHF 182.14MCHF 11.40M

Financial position

MeasureOculisIndustry median
Current Ratio5.962.65
Quick Ratio2.212.21
Interest Coverage-98.05-116.78

Cash flow (trailing twelve months)

MeasureOculisIndustry median
Operating Cash Flow-CHF 66.30M-CHF 51.26M
Capital Expenditures-CHF 301.00K-CHF 446.00K
Free Cash Flow-CHF 66.61M-CHF 51.97M
FCF Per Share-1.11 CHF-1.11 CHF

Efficiency

MeasureOculisIndustry median
Employee Count6049

Shares

MeasureOculisIndustry median
Shares Outstanding60,089,30050,231,950
Shares Change (YoY)29.3%20.2%
Float53,139,10041,812,550
Shares Held by Insiders11.6%19.3%

Taxes

MeasureOculisIndustry median
Income Tax-CHF 186.00KCHF 0

Calculated by StockData from Oculis's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.